EUVIMEDEUVIMED entdecken
Crossref

0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort

R.L. Richmond, G. Micevic

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S149

DOI: 10.1016/j.jid.2026.06.892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von R.L. Richmond und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Richmond, R., & Micevic, G. (2026). 0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort. Journal of Investigative Dermatology, 146(8), S149. https://doi.org/10.1016/j.jid.2026.06.892

Vancouver

Richmond R, Micevic G. 0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort. Journal of Investigative Dermatology. 2026;146(8):S149. doi:10.1016/j.jid.2026.06.892

BibTeX
@article{Richmond2026,
  author = {Richmond, R.L. and Micevic, G.},
  title = {0861 Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S149},
  doi = {10.1016/j.jid.2026.06.892}
}
Kostenlos starten →